Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-22
2010-10-12
Helms, Larry R. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C536S023100
Reexamination Certificate
active
07811986
ABSTRACT:
The present invention relates to cDNA sequences from a region of amplification on chromosome20associated with disease. The sequences can be used in hybridization methods for the identification of chromosomal abnormalities associated with various diseases. The sequences can also be used for treatment of diseases.
REFERENCES:
patent: 5472842 (1995-12-01), Stokke et al.
patent: 5633365 (1997-05-01), Stokke et al.
patent: 5801021 (1998-09-01), Gray et al.
patent: 5892010 (1999-04-01), Gray et al.
patent: 6268184 (2001-07-01), Gray et al.
patent: 6808878 (2004-10-01), Gray et al.
patent: 7049424 (2006-05-01), Gray et al.
patent: 7413899 (2008-08-01), Gray et al.
patent: 7455964 (2008-11-01), Gray et al.
patent: 2006/0257895 (2006-11-01), Pinkel et al.
patent: 2006/0292591 (2006-12-01), Gray et al.
patent: 2009/0155789 (2009-06-01), Gray et al.
patent: 774736 (2004-10-01), None
patent: 2257821 (1997-07-01), None
patent: 0 430402 (1991-05-01), None
patent: 0 492214 (1992-07-01), None
patent: 0 533 006 (1993-03-01), None
patent: 0 571 911 (1993-12-01), None
patent: 960197 (1999-12-01), None
patent: H05-506998 (1993-10-01), None
patent: H07-289297 (1995-11-01), None
patent: H08-092285 (1996-04-01), None
patent: WO 90/05789 (1990-05-01), None
patent: WO 93/18186 (1993-09-01), None
patent: WO 93/24514 (1993-12-01), None
patent: WO 93/25671 (1993-12-01), None
patent: WO 94/01548 (1994-12-01), None
patent: WO 95/14772 (1995-01-01), None
patent: WO 95/09929 (1995-04-01), None
patent: WO 95/33480 (1995-12-01), None
patent: WO 97/14811 (1997-04-01), None
patent: WO 98/02539 (1998-01-01), None
patent: WO 03/027263 (2003-04-01), None
Accession No. H16954 Jun. 29, 1995.
Accession No. G11697 Oct. 19, 1995.
Accession No. G25553 May 31, 1996.
Accession No. G27410 Jun. 28, 1996.
Accession No. H12950 Jun. 27, 1995.
Accession No. H16953 Jun. 29, 1995.
Accession No. N32481 Jan. 10, 1996.
Accession No. H40682 Aug. 16, 1995.
Accession No. N70546 Mar. 14, 1996.
Accession No. N93893 Apr. 5, 1996.
Accession No. Q63862 (Jan. 29, 1995).
Database EST-STS on MPsrch Accession No. G08049, Murray et al.,Cooperative human linkage center, Aug. 8, 1995.
Genbank Accession No. N78571 (Mar. 29, 1996) Hillier et al.
Genbank Accession No. W05407 (Apr. 23, 1996) Hillier et al.
Genbank Accession No. X17105 (Nov. 9, 1995) Bergsman et al.
Austrailian Office Action dated Sep. 1, 1999 issued in AU3602097.
Austrailian Office Action dated Sep. 25, 2002 issued in AU4808601.
Austrailian Notice of Acceptance dated May 27, 2004 issued in AU4808601.
Canadian Office Action dated Jan. 7, 2004 issued in CA2257821.
Canadian Office Action dated Dec. 7, 2005 issued in CA2257821.
Canadian Office Action dated Dec. 16, 2008 issued in CA2257821.
Canadian Notice of Acceptance dated Nov. 17, 2009 issued in CA2257821.
Canadian Office Action dated Sep. 3, 2004 issued in CA2231349.
Canadian Office Action dated Jul. 4, 2008 issued in CA2231349.
Canadian Notice of Allowance dated Mar. 10, 2009 issued in CA2231349.
European Office Action dated May 14, 2004 issued in EP97 932 612.
European Supplemental Search Report dated Sep. 16, 2003 issued in EP97 932 612.
European Partial Search Report dated May 30, 2003 issued in EP97 932 612.
European Office Action dated Nov. 8, 2005 issued in EP97 932 612.
European Office Action dated Oct. 9, 2006 issued in EP97 932 612.
European Office Action dated Sep. 11, 2007 issued in EP97 932 612.
European Notification of Grant dated Jul. 4, 2008 issued in EP97 932 612.
European Office Action dated Sep. 20, 2006 issued in EP96 93 6256.5.
European Search Report dated Nov. 7, 2002 issued in EP96 93 6256.5.
European Partial Search Report dated Jun. 15, 2009 issued in EPO9 00 2002.5.
European Extended Search Report dated Sep. 9, 2009 issued in EPO9 00 2002.5.
European Office Action dated Feb. 24, 2010 issued in EPO9 00 2002.5.
International Serach Report dated Sep. 15, 1997 issued in PCT/US97/12343 (WO 98/002539).
International Preliminary Examination Report dated Sep. 16, 1998 issued in PCT/US97/12343 (WO 98/002539).
PCT International Search Report dated Jan. 30, 1997 issued in PCT/US96/16085 (WO 97/14811).
Japanese Office Action dated Oct. 21, 2003 issued in JP 9-515857 with Translation.
Japanese Office Action dated Aug. 16, 2005 issued in JP 9-515857 with Translation.
Japanese Office Action dated Jul. 31, 2007 issued in JP 9-515857 with Translation.
Japanese Office Action dated Nov. 13, 2007 issued in JP 10-506264 with Translation.
Japanese Office Action dated Feb. 10, 2009 issued in JP 10-506264 with Translation.
Japanese Office Action dated Feb. 3, 2009 issued in JP 2008-126229 with Translation.
US Office Action dated Jun. 9, 1997 issued in U.S. Appl. No. 08/546,130.
US Notice of Allowance dated Feb. 3, 1998 issued in U.S. Appl. No. 08/546,130.
US Office Action dated Mar. 5, 2009 issued in U.S. Appl. No. 09/066,641.
US Office Action dated Nov. 19, 1999 issued in U.S. Appl. No. 09/066,641.
US Final Office Action dated Aug. 14, 2000 issued in U.S. Appl. No. 09/066,641.
US Notice of Allowance dated Feb. 28, 2001 issued in U.S. Appl. No. 09/066,641.
US Office Action dated Apr. 21, 1997 issued in U.S. Appl. No. 08/680,395.
US Office Action dated Jan. 21, 1998 issued in U.S. Appl. No. 08/680,395.
US Notice of Allowance and Issued Claims dated Sep. 28, 1998 issued in U.S. Appl. No. 08/680,395.
US Office Action dated Jun. 9, 1998 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Sep. 13, 1999 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Jun. 21, 2000 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Mar. 27, 2001 issued in U.S. Appl. No. 08/731,499.
US Final Office Action dated Jan. 2, 2002 issued in U.S. Appl. No. 08/731,499.
US Final Office Action dated Apr. 9, 2003 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Jan. 9, 2004 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Oct. 6, 2004 issued in U.S. Appl. No. 08/731,499.
US Notice of Allowance and Allowed Claims dated Oct. 19, 2005 issued in U.S. Appl. No. 08/731,499.
US Office Action dated Sep. 9, 1997 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Oct. 16, 1998 issued in U.S. Appl. No. 08/785,532.
US Final Office Action dated Jun. 28, 1999 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Jan. 30, 2001 issued in U.S. Appl. No. 08/785,532.
US Final Office Action dated Oct. 19, 2001 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Mar. 11, 2003 issued in U.S. Appl. No. 08/785,532.
US Final Office Action dated Mar. 4, 2004 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Jun. 14, 2005 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Mar. 22, 2006 issued in U.S. Appl. No. 08/785,532.
US Final Office Action dated Feb. 15, 2007 issued in U.S. Appl. No. 08/785,532.
US Notice of Allowance dated Sep. 19, 2007 issued in U.S. Appl. No. 08/785,532.
US Notice of Allowance dated Feb. 14, 2008 issued in U.S. Appl. No. 08/785,532.
US Supplemental Notice of Allowance dated May 16, 2008 issued in U.S. Appl. No. 08/785,532.
US Office Action dated Feb. 7, 2000 issued in U.S. Appl. No. 08/892,695.
US Office Action dated Nov. 8, 2000 issued in U.S. Appl. No. 08/892,695.
US Final Office Action dated Jul. 31, 2001 issued in U.S. Appl. No. 08/892,695.
US Office Action dated Mar. 26, 2003 issued in U.S. Appl. No. 08/892,695.
US Notice of Allowance and Allowed Claims dated Apr. 20, 2004 issued in U.S. Appl. No. 08/892,695.
US Office Action dated Jul. 24, 2007 issued in U.S. Appl. No. 11/349,066.
US Notice of Allowance dated Apr. 18, 2008 issued in U.S. Appl. No. 11/349,066.
ATCC/NIH Repository Catalogue, 1992, p. 113-114.
Beeler et al. (1994) “Prokaryotic Expression Cloning of a Novel Human Tyrosine Kinase,”Molecular and Cellular Biology, 14: 982-988.
Benz et al., Journal of the National Cancer Institute, Nov. 1989, 81(22):1704-1709.
Bergerheim et al., “Deletion Mapping of Chromosomes 8, 10, and 16 in Human Prostatic Carcinoma,”Genes. Chromosomes&Cancer, vol. 3, pp. 215-220 (1991).
Berns et al., Gene, 1995, 159:11-18.
Blennow et al. “Complete charac
Collins Colin Conrad
Godfrey Tony
Gray Joe W.
Hwang Soo-in
Kowbel David
Helms Larry R.
Natarajan Meera
The Hospital for Sick Children
The Regents of The University of California
Weaver Austin Villeneuve & Sampson LLP
LandOfFree
Genes from the 20Q13 amplicon and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genes from the 20Q13 amplicon and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes from the 20Q13 amplicon and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219973